These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 17973948)
61. CD79a is heterogeneously expressed in neoplastic and normal myeloid precursors and megakaryocytes in an antibody clone-dependent manner. Bhargava P; Kallakury BV; Ross JS; Azumi N; Bagg A Am J Clin Pathol; 2007 Aug; 128(2):306-13. PubMed ID: 17638667 [TBL] [Abstract][Full Text] [Related]
62. New classification of acute myeloid leukemia and precursor-related neoplasms: changes and unsolved issues. Falini B; Tiacci E; Martelli MP; Ascani S; Pileri SA Discov Med; 2010 Oct; 10(53):281-92. PubMed ID: 21034669 [TBL] [Abstract][Full Text] [Related]
63. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation. Rausei-Mills V; Chang KL; Gaal KK; Weiss LM; Huang Q Am J Clin Pathol; 2008 Apr; 129(4):624-9. PubMed ID: 18343790 [TBL] [Abstract][Full Text] [Related]
64. An updated approach to the diagnosis of myeloid leukemia cutis. Cronin DM; George TI; Sundram UN Am J Clin Pathol; 2009 Jul; 132(1):101-10. PubMed ID: 19864240 [TBL] [Abstract][Full Text] [Related]
66. Advances in understanding the biology and genetics of acute myelocytic leukemia. McKenzie SB Clin Lab Sci; 2005; 18(1):28-37. PubMed ID: 15747784 [TBL] [Abstract][Full Text] [Related]
67. Diagnostic value of histology and immunohistochemistry in myelodysplastic syndromes. Horny HP; Sotlar K; Valent P Leuk Res; 2007 Dec; 31(12):1609-16. PubMed ID: 17604834 [TBL] [Abstract][Full Text] [Related]
68. Immunocytochemical detection of megakaryocytes by endothelial markers: a comparative study. Calapso P; Vitarelli E; Crisafulli C; Tuccari G Pathologica; 1992; 84(1090):215-23. PubMed ID: 1437309 [TBL] [Abstract][Full Text] [Related]
69. [A histopathological study of bone marrow in acute myeloid leukemia. Bone marrow biopsy changes before chemotherapy and comparison with bone marrow smears]. Pu Q; Tang CS; Zhou RH Zhonghua Nei Ke Za Zhi; 1991 Sep; 30(9):566-8, 595. PubMed ID: 1806340 [TBL] [Abstract][Full Text] [Related]
70. Defective in vitro growth of primitive hematopoietic cells from pediatric patients with acute myeloid leukemia. Dorantes-Acosta E; Chávez-González A; Santos JI; Medina-Sanson A; Mayani H Pediatr Blood Cancer; 2008 Dec; 51(6):741-6. PubMed ID: 18680148 [TBL] [Abstract][Full Text] [Related]
71. Evaluation of bone marrow specimens with acute myelogenous leukemia for CD34, CD15, CD117, and myeloperoxidase. Dunphy CH; Polski JM; Evans HL; Gardner LJ Arch Pathol Lab Med; 2001 Aug; 125(8):1063-9. PubMed ID: 11473459 [TBL] [Abstract][Full Text] [Related]
72. Immunophenotypic profile of acute leukemia: critical analysis and insights gained at a tertiary care center in India. Gujral S; Badrinath Y; Kumar A; Subramanian PG; Raje G; Jain H; Pais A; Amre Kadam PS; Banavali SD; Arora B; Kumar P; Hari Menon VG; Kurkure PA; Parikh PM; Mahadik S; Chogule AB; Shinde SC; Nair CN Cytometry B Clin Cytom; 2009 May; 76(3):199-205. PubMed ID: 18803279 [TBL] [Abstract][Full Text] [Related]
73. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations. Harada Y; Harada H J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039 [TBL] [Abstract][Full Text] [Related]
74. Myelodysplastic/myeloproliferative disease with erythropoietic hyperplasia (erythroid preleukemia) and the unique translocation (8;9)(p23;p24): first description of a case. Heiss S; Erdel M; Gunsilius E; Nachbaur D; Tzankov A Hum Pathol; 2005 Oct; 36(10):1148-51. PubMed ID: 16226118 [TBL] [Abstract][Full Text] [Related]
75. FLT3 internal tandem duplication during myelodysplastic syndrome follow-up: a marker of transformation to acute myeloid leukemia. Pinheiro RF; de Sá Moreira E; Silva MR; Alberto FL; Chauffaille Mde L Cancer Genet Cytogenet; 2008 Jun; 183(2):89-93. PubMed ID: 18503825 [TBL] [Abstract][Full Text] [Related]
76. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool? Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G; Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215 [TBL] [Abstract][Full Text] [Related]
77. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Stetler-Stevenson M; Arthur DC; Jabbour N; Xie XY; Molldrem J; Barrett AJ; Venzon D; Rick ME Blood; 2001 Aug; 98(4):979-87. PubMed ID: 11493442 [TBL] [Abstract][Full Text] [Related]
78. Acute myeloid leukaemia and myelodysplastic syndromes with 50% or greater erythroblasts: a diagnostic conundrum. Wong E; Juneja S Pathology; 2015 Jun; 47(4):289-93. PubMed ID: 25938365 [TBL] [Abstract][Full Text] [Related]
79. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells. Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702 [TBL] [Abstract][Full Text] [Related]
80. [Haematological characteristics, FAB and WHO classification of 153 cases of myeloid acute leukaemia in Tunisia]. Braham-Jmili N; Sendi-Senana H; Labiadh S; Ben Abdelali R; Ben Abdelaziz A; Khelif A; Saad A; Kortas M Ann Biol Clin (Paris); 2006; 64(5):457-65. PubMed ID: 17040877 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]